Shanmuga Hospital IPO Logo

Shanmuga Hospital IPO

Live Updates, GMP, Subscription Data, and Financial Details

IPO Overview

Listed
Dates Feb 13 to Feb 17 2025
Price Band ₹54
Current GMP ₹54(0.00%)
Subscription 2.5 times

IPO Details

IPO Date
February 13, 2025 to February 17, 2025
Listing Date
February 21, 2025
Face Value
₹10 per share
Issue Price
₹54 per share
Lot Size
2,000 Shares
Total Issue Size
38,18,000 shares (aggregating up to ₹20.62 Cr)
Fresh Issue
38,18,000 shares (aggregating up to ₹20.62 Cr)
Issue Type
Fixed Price Issue IPO
Listing At
BSE SME
Share Holding Pre Issue
97,95,000 shares
Share Holding Post Issue
1,36,13,000 shares
Market Maker Portion
1,92,000 sharesBlack Fox Financial Private Limited

IPO Subscription Details

Market Maker
1
Non-Institutional Buyers***
0.6
Retail Investors
4.4
Total **
2.5

Day Wise Sub

DayDay 1 Feb 13, 2025
NII*0.19
Retail1.11
Total0.65
DayDay 2 Feb 14, 2025
NII*0.24
Retail2.25
Total1.24
DayDay 3 Feb 17, 2025
NII*0.6
Retail4.4
Total2.5

Day Wise GMP

Date21-02-2025
Price54.00
GMP3(5.56%)
Estimate List Price57
Date20-02-2025
Price54.00
GMP3(5.56%)
Estimate List Price57
Date19-02-2025
Price54.00
GMP3(5.56%)
Estimate List Price57
Date18-02-2025
Price54.00
GMP3(5.56%)
Estimate List Price57
Date17-02-2025
Price54.00
GMP3(5.56%)
Estimate List Price57
Date16-02-2025
Price54.00
GMP3(5.56%)
Estimate List Price57
Date15-02-2025
Price54.00
GMP3(5.56%)
Estimate List Price57
Date14-02-2025
Price54.00
GMP3(5.56%)
Estimate List Price57
Date13-02-2025
Price54.00
GMP8(14.81%)
Estimate List Price62
Date12-02-2025
Price54.00
GMP8(14.81%)
Estimate List Price62
Date11-02-2025
Price54.00
GMP8(14.81%)
Estimate List Price62
Date10-02-2025
Price54.00
GMP8(14.81%)
Estimate List Price62
Date09-02-2025
Price54.00
GMP0(0.00%)
Estimate List Price54
Date08-02-2025
Price54.00
GMP0(0.00%)
Estimate List Price54

IPO Important Dates

IPO Open Date
Thu, Feb 13, 2025
IPO Close Date
Mon, Feb 17, 2025
Tentative Allotment
Tue, Feb 18, 2025
Initiation of Refunds
Wed, Feb 19, 2025
Credit of Shares to Demat
Wed, Feb 19, 2025
Tentative Listing Date
Fri, Feb 21, 2025
Cut-off time for UPI mandate confirmation
5 PM on February 17, 2025

IPO Lot Size

ApplicationRetail (Min)
Lots1
Shares2000
Amount₹1,08,000
ApplicationRetail (Max)
Lots1
Shares2000
Amount₹1,08,000
ApplicationHNI (Min)
Lots2
Shares4,000
Amount₹2,16,000

Financial Information

Period EndedPeriod Ended
30 Sep 202430 Sep 2024
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
30 Sep 202436.53
31 Mar 202433.92
31 Mar 202323.05
Period EndedRevenue
30 Sep 202424.83
31 Mar 202443.39
31 Mar 202339.5
Period EndedProfit After Tax
30 Sep 20242.39
31 Mar 20245.26
31 Mar 20234.76
Period EndedNet Worth
30 Sep 202419.53
31 Mar 202417.13
31 Mar 202311.82
Period EndedReserves and Surplus
30 Sep 20249.73
31 Mar 20247.34
31 Mar 202311.74
Period EndedTotal Borrowing
30 Sep 20249.76
31 Mar 20249.02
31 Mar 20237.65

IPO Reservation

Anchor Investor Shares Offered
-
Market Maker Shares Offered
1,92,000 (5.03%)
Other Shares Offered
18,13,000 (47.49%)
Retail Shares Offered
18,13,000 (47.49%)
Total Shares Offered
38,18,001 (100%)

Information about company

Incorporated in 2020, Shanmuga Hospital Limited is a Multispecialty Hospital. Shanmuga Hospital is equipped with advanced healthcare technology and having 151 bed capacity, it addresses the community’s medical needs, serving patients from nearby regions. Accredited by NABH and NABL, the hospital is dedicated to providing high-quality healthcare services, including prevention, treatment, and rehabilitation. Located at 51/24 Saradha College Road, Salem, Tamil Nadu, the hospital spans 45,311 square feet across two blocks and three floors, offering IPD and OPD services with a dedicated team. Hospital Units: Shanmuga Pharmacy & Diagnostics:The hospital operates Shanmuga Pharmacy, providing medications to OPD and IPD patients. Shanmuga Diagnostics offers reliable pathology services for accurate medical evaluations and treatment planning. Shanmuga Clinics:The hospital extends services through Shanmuga Clinics, providing specialized consultations and treatments in Salem. Critical patients are transferred to the main hospital for advanced care when necessary. Services: Oncology, General Surgery, Orthopaedics, Cardiology,General Medicine, Paediatrics & Neonatology, Neurology, Endocrinology & Diabetes Department, Plastic Surgery, Respiratory Medicine. As on August 31, 2024, the hospital had 72 doctors, out of whom 9 doctors were Resident Doctors, 7 Junior Doctors, 28 Senior Consulting Doctors and 28 Consulting Visiting Doctors. Competitive Strengths: Oncology Presence Rich experience of promoters of over four decades Cost Affordable to Regional Population Specialized Equipment like LINAC, CATHLAB, MRI, MODULAR OT Tie-up with Government and Private Insurance Companies

Objectives of IPO

The Objects of the Issue are: Funding Capital Expenditure towards Purchase of additional Medical Equipment General Corporate Purposes

Disclaimer

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App